Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Stocks
Indices
Market Movers
Commodities
Cryptocurrencies
Forex
Technical Analysis
Economic Indicator
Other
Important Only
RPT-BREAKINGVIEWS-Longer Jefferies courtship would benefit Sumitomo
By Jeffrey Goldfarb and Una GalaniNEW YORK, March 24 (Reuters Breakingviews) - If Sumitomo Mitsui Financial 8316.T wants to go deeper into the United States, Motown would be a better place to start than Wall Street. The renowned Detroit record label issued The Supremes’ chart-topper “You Can’t Hurry...
Reuters
Wed, Mar 25
RPT-BREAKINGVIEWS-China AI labs face growing open-source dilemma
By Robyn Mak HONG KONG, March 25 (Reuters Breakingviews) - To open-source or not may soon be the trickiest question facing China's top artificial intelligence companies. The $300 billion Alibaba 9988.HK and compatriots made most of their models free and available for anyone to use, which in t...
Reuters
Wed, Mar 25
Volatus Aerospace Expands Global Training Network Through Strategic Partnership With University Of Technology, Jamaica
Volatus Aerospace Inc FLT.TO:VOLATUS AEROSPACE EXPANDS GLOBAL TRAINING NETWORK THROUGH STRATEGIC PARTNERSHIP WITH UNIVERSITY OF TECHNOLOGY, JAMAICA
Reuters
Wed, Mar 25
Anavex Life Sciences Provides Update On Regulatory Review In The EU For Blarcamesine To Treat Early Alzheimer’S Disease
Anavex Life Sciences Corp AVXL.O:ANAVEX LIFE SCIENCES PROVIDES UPDATE ON REGULATORY REVIEW IN THE EU FOR BLARCAMESINE TO TREAT EARLY ALZHEIMER’S DISEASEANAVEX LIFE SCIENCES CORP - WITHDRAWS EU MARKETING AUTHORIZATION APPLICATION FOR BLARCAMESINEANAVEX LIFE SCIENCES CORP - REMAINS COMMITTED TO CLINIC...
Reuters
Wed, Mar 25
Marvel Biosciences Selects Novotech As Cro For Its Phase I Clinical Trial Of Mb-204
Marvel Biosciences Corp MRVL.V:MARVEL BIOSCIENCES SELECTS NOVOTECH AS CRO FOR ITS PHASE I CLINICAL TRIAL OF MB-204
Reuters
Wed, Mar 25
American Express Launches New Graphite Business Cash Unlimited Card
March 25 (Reuters) - American Express Co AXP.N:AMERICAN EXPRESS: LAUNCHES NEW GRAPHITE BUSINESS CASH UNLIMITED CARDAMERICAN EXPRESS: BUSINESS MEMBERSHIP TO EXPAND WITH EIGHT NEW PRODUCTS, BENEFITS, AI-POWERED CAPABILITIES FOR BUSINESS OF ALL SIZES IN 2026AMERICAN EXPRESS: NEW $300 CHATGPT BUSINESS C...
Reuters
Wed, Mar 25
Street View: Karyopharm's cancer drug trial results limit regulatory odds
Karyopharm Therapeutics KPTI.O said on Tuesday its therapy led to significant reduction in spleen size in a late-stage study of patients with myelofibrosis, a rare blood cancer, meeting only one of its two main goalsThe drug combination failed to meet the study's second main goal of statisticall...
Reuters
Wed, Mar 25
Piper Sandler bullish on National Bank Holdings, starts coverage with 'overweight' rating
Piper Sandler assumes coverage of National Bank Holdings Corp NBHC.N with an "overweight" rating; sets PT of $48, representing a 24.8% upside to the stock's last closeBrokerage says NBHC has been able to generate a peer leading net interest margin (NIM) largely driven by its disciplined ...
Reuters
Wed, Mar 25
Meta boosts top executives' pay with stock options as AI race heats up
By Mrinmay Dey and Katie Paul March 24 (Reuters) - Meta Platforms has offered top executives stock options that could pay out hundreds of millions of dollars and are tied to lifting its valuation six-fold to more than $9 trillion, in a bid to retain talent and spur aggressive growth in the AI era...
Reuters
Wed, Mar 25
Morning News Call - Canada, March 25
To access a PDF version of this newsletter, please click hereYou can read Morning News Call Canada via TOPNEWS Canada page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-pageCOMPANIES REPORTING RESULTSMarc...
Reuters
Wed, Mar 25
Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
March 25 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A:APIMEDS PHARMACEUTICALS - APPOINTS YOUNGJIK CHO AS CHAIRMAN OF THE BOARD - SEC FILINGAPIMEDS PHARMACEUTICALS- ON MAR 20, REMOVES ELONA KOGAN, JAKAP KOO, CAROL O'DONNELL, BENNETT WEINTRAUB AS DIRECTORS EFFECTIVE IMMEDIATELY - SEC FILINGAP...
Reuters
Wed, Mar 25
Adani Eyes Partnerships With Meta, Google Amid Data Center Boom - Bloomberg News
March 25 (Reuters) - ADANI EYES PARTNERSHIPS WITH META, GOOGLE AMID DATA CENTER BOOM - BLOOMBERG NEWSWALMART'S FLIPKART IS ALSO ENGAGED IN TALKS WITH ADANI GROUP, IS EXPLORING SITES ACROSS INDIAN STATES FOR CENTERS- BLOOMBERG NEWSSource text: https://tinyurl.com/2evjkjtd
Reuters
Wed, Mar 25
N Korea's Kim welcomes fellow Putin ally Lukashenko with fanfare
Both leaders back Russia's war in UkraineUnder sanctions, Belarus and N Korea plan friendship pactLukashenko trip comes six days after he met Trump's envoyBy Mark Trevelyan March 25 (Reuters) - North Korean leader Kim Jong Un met Belarusian President Alexander Lukashenko in Pyongyang on W...
Reuters
Wed, Mar 25
Local Bounti Q4 sales rise on US facility growth
OverviewU.S. indoor agriculture firm's preliminary Q4 sales rose 24% yr/yr, driven by facility outputPreliminary Q4 net loss narrowed, mainly due to reduced interest expense after debt restructuringCompany received $15 mln investment from strategic investor in March 2026OutlookCompany expects se...
Reuters
Wed, Mar 25
Italian Gunmaker Beretta Pushes To Raise Its Stake In Sturm Ruger To 30 Per Cent - FT
March 25 (Reuters) - ITALIAN GUNMAKER BERETTA PUSHES TO RAISE ITS STAKE IN STURM RUGER TO 30 PER CENT - FTSource text: https://tinyurl.com/bdfhw2mr
Reuters
Wed, Mar 25
Pentagon says it will boost defense production with BAE, LMT & Honeywell
WASHINGTON, March 25 (Reuters) - The Pentagon said on Wednesday it had reached framework deals with BAEBAES.L, Lockheed LMT.N and HoneywellHON.O to boost production of several defense systems and munitions.
Reuters
Wed, Mar 25
Israel's Cognyte misses Q4 operating income expectations
OverviewIsraeli investigative analytics software firm's Q4 revenue grew 12.4% yr/yrQ4 operating income missed analyst expectations despite improvement from prior yearCompany expanded share repurchase program and ended quarter with no debtOutlookCognyte expects fiscal 2027 revenue of $448 mln, +/...
Reuters
Wed, Mar 25
Chewy Q4 adj EPS top estimates on customer, margin growth
OverviewUS pet products e-tailer reported fiscal Q4 revenue up slightly, slightly missing analyst expectationsAdjusted EPS for fiscal Q4 beat analyst expectationsCompany attributed results to strong customer growth and expanding marginsOutlookCompany did not provide specific guidance for the current...
Reuters
Wed, Mar 25
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
OverviewUS retinal disease biotech posted 2025 net loss, reversing prior yr profitR&D and G&A expenses rose in 2025, mainly due to clinical trial activity and personnelCompany ended 2025 with $17.1 mln in cash, expects runway into late 2027OutlookCompany expects existing cash to fund operati...
Reuters
Wed, Mar 25
Maze Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs
OverviewUS biopharmaceutical firm's Q4 net loss missed analyst expectations, income from operations also missedPretax profit for Q4 slightly beat analyst estimatesCompany announced positive Phase 2 HORIZON trial data for MZE829 in AMKD, plans pivotal programOutlookCompany plans to advance MZE829...
Reuters
Wed, Mar 25
1
...
66
67
68
68
/
300
69
70
...
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free